Benznidazole ( DrugBank: Benznidazole )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
65	Primary immunodeficiency	2

65. Primary immunodeficiency

---

Clinical trials : 500 /  Drugs : 614 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 217

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02369978 (ClinicalTrials.gov)	August 2015	17/2/2015	CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)	Cardiovascular Health Investigation and Collaboration From Countries of America to Assess the Markers and Outcomes of Chagas Disease (CHICAMOCHA-3) - EQUITY (Equivalence of Usual Interventions for Trypanosomiasis)	Chagas Disease	Drug: Nifurtimox;Drug: Benznidazole;Drug: Placebo	Universidad Autónoma de Bucaramanga	Fundación Cardioinfantil Instituto de Cardiología;Instituto Nacional de Salud (Colombia);Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben	Recruiting	20 Years	55 Years	All	500	Phase 2/Phase 3	Colombia
2	NCT00123916 (ClinicalTrials.gov)	November 2004	21/7/2005	BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease	Benznidazole Evaluation for Interrupting Trypanosomiasis - The BENEFIT Trial	Chagas Disease;Trypanosomiasis;Heart Disease	Drug: Benznidazole;Drug: Placebo	Population Health Research Institute	Canadian Institutes of Health Research (CIHR);World Health Organization;Instituto Dante Pazzanese de Cardiologia;University of Sao Paulo	Completed	18 Years	75 Years	All	2854	Phase 3	Argentina;Bolivia;Brazil;Colombia;El Salvador;Canada